These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate Vaccine (PRP-T {ActHIBTM, OmniHIBTM}), manufactured by Pasteur Merieux Vaccins, and TETRAMUNETM, manufactured by Lederle Laboratories/Praxis Biologics. This statement also updates recommendations for use of other available Haemophilus b vaccines (PRP-D {ProHIBiT(registered)}; HbOC {HibTITER(registered)}; and PRP-OMP {PedvaxHIB(registered)}) for infants and children.

  • Recommendation
  • Americas
  • United States of America
  • Haemophilus influenzae type B